Company profile: Boca Biolistics
1.1 - Company Overview
Company description
- Provider of hybrid CRO and biobank services, delivering human biospecimens across oncology and other diseases; end-to-end contract research to support development and market approval of diagnostic technologies; CLIA-certified, CAP-accredited reference lab testing; COVID-19 serology and PCR; and oncology research solutions combining clinical research, data analytics, and industry leading clinical and molecular datasets to enable precision medicine.
Products and services
- CONTRACT RESEARCH ORGANIZATION: Architects end-to-end programs supporting development and market approval of diagnostic technologies, leveraging a vertically integrated, data-centric platform to accelerate cutting-edge advancements
- BIOBANX: Supplies a broad range of human biospecimens across many indications, focusing on oncology and other diseases, integrated with industry-leading clinical and molecular datasets via a vertically integrated biorepository
- ONCOLOGY RESEARCH SOLUTIONS: Delivers data-centric cancer research systems combining biospecimen provision, laboratory services, clinical research capabilities, and data analytics to advance oncology programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Boca Biolistics
Inotiv
HQ: United States
Website
- Description: Provider of biopharmaceutical analytical, reproductive toxicology, and medical device testing, offering in vivo preclinical efficacy and toxicity, DMPK method development and bioanalysis, genetic toxicology, histology, and anatomical, clinical, and medical device pathology, plus consulting in DMPK data analysis, biomarker analysis, and bioequivalence to support biologic and small molecule drug development from discovery to First-in-Human.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inotiv company profile →
Gallus BioPharma
HQ: United States
Website
- Description: Provider of contract manufacturing and development services for mammalian cell culture-derived biologics, supplying clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally, with capabilities in process and analytical development, process validation, cell banking, stability testing, QA/QC, regulatory support, and aseptic fill-finish (vial filling, inspection, labeling).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gallus BioPharma company profile →
Triangle Insights Group
HQ: United States
Website
- Description: Provider of strategy consulting services to life sciences organizations, guiding leaders on critical business issues with deep industry knowledge. Offerings include pricing and market access, commercial strategy and execution, R&D prioritization, commercial launch strategy, due diligence, and portfolio strategy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triangle Insights Group company profile →
Ardena
HQ: Belgium
Website
- Description: Provider of pharmaceutical development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ardena company profile →
Syner-G BioPharma
HQ: United States
Website
- Description: Provider of pharmaceutical development and CMC solutions; cGMP and quality/compliance services; regulatory strategy and submissions spanning CMC, nonclinical, and clinical; functional outsourcing partnerships with dedicated regulatory staff; medical writing for scientifically accurate, compliant documents; and CMC consulting focused on strategy, compliance, and process optimization in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syner-G BioPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Boca Biolistics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Boca Biolistics
2.2 - Growth funds investing in similar companies to Boca Biolistics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Boca Biolistics
4.2 - Public trading comparable groups for Boca Biolistics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →